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ABSTRACT
Background: Mediterranean diets limit red meat consumption and
increase intakes of high-phytate foods, a combination that could
reduce iron status. Conversely, higher intakes of fish, a good source
of selenium, could increase selenium status.
Objectives: A 1-y randomized controlled trial [New Dietary
Strategies Addressing the Specific Needs of the Elderly Population
for Healthy Aging in Europe (NU-AGE)] was carried out in older
Europeans to investigate the effects of consuming a Mediterranean-
style diet on indices of inflammation and changes in nutritional
status.
Methods: Selenium and iron intakes and status biomarkers were
measured at baseline and after 1 y in 1294 people aged 65–
79 y from 5 European countries (France, Italy, the Netherlands,
Poland, and the United Kingdom) who had been randomly allocated
either to a Mediterranean-style diet or to remain on their habitual,
Western diet.
Results: Estimated selenium intakes increased significantly with
the intervention group (P < 0.01), but were not accompanied
by changes in serum selenium concentrations. Iron intakes also
increased (P < 0.001), but there was no change in iron status.
However, when stratified by study center, there were positive effects
of the intervention on iron status for serum ferritin for participants
in Italy (P = 0.04) and France (P = 0.04) and on soluble transferrin
receptor (sTfR) for participants in Poland (P < 0.01). Meat intake
decreased and fish intake increased to a greater degree in the
intervention group, relative to the controls (P < 0.01 for both), but
the overall effects of the intervention on meat and fish intakes were
mainly driven by data from Poland and France. Changes in serum
selenium in the intervention group were associated with greater
changes in serum ferritin (P = 0.01) and body iron (P = 0.01), but
not sTfR (P = 0.73); there were no study center × selenium status
interactions for the iron biomarkers.
Conclusions: Consuming a Mediterranean-style diet for 1 y had no
overall effect on iron or selenium status, although there were positive
effects on biomarkers of iron status in some countries. The NU-AGE
trial was registered at clinicaltrials.gov as NCT01754012. Am J
Clin Nutr 2020;111:98–109.
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Introduction
AMediterranean dietary pattern (MD) is widely recommended
for the prevention of chronic diseases (1, 2). Although only a few
studies have estimated the nutritional value of the Mediterranean
diet, they consistently report that higher adherence results in
higher iron intakes (3–5). However, serum ferritin concentrations,
a marker of body iron stores, were reported to be 2-fold lower
in Crete (Southern Europe) than Zutphen (Northern Europe)
(6), suggesting that higher iron intakes from a Mediterranean
diet do not necessarily result in higher iron statuses. In elderly
Spanish people consuming a Mediterranean (Atlantic) diet,
there was a positive association between meat intake and
hemoglobin concentration, indicating a key role for meat in iron
nutrition (7).
In the United States, it has been estimated that approximately
11% of men and 10% of women aged 65 and above are anemic
(8). Although physiological iron requirements do not differ
between adults and the elderly, chronic low-grade inflammation,
common in old age, reduces iron absorption through hepcidin
regulation. The soluble transferrin receptor (sTfR)-ferritin index
appears to be the most useful method for identifying iron
deficiencies in older people (9).
The Mediterranean diet is associated with higher intakes
of fish, among the richest sources of dietary selenium, and
it has been reported that 15% of the variance in plasma
selenium in subjects aged 69 y or over was explained by fish
consumption (10). Low selenium intakes have been implicated in
the development of sarcopenia (11), and selenium may modulate
susceptibility to pathogens and provide immune defenses against
microbes (12), both of which are especially important for elderly
people.
We hypothesized that aMediterranean diet with limited intakes
of red and processed meat, an important supply of bioavailable
iron (13), together with a higher consumption of whole-grain ce-
reals and nuts containing phytate, which inhibits iron absorption
(14, 15), would result in lower iron status. Conversely, higher
intakes of fish, a good source of selenium (16, 17), could increase
selenium status. It has been reported that lower serum selenium
concentrations are associated with anemia in older women (18);
therefore, we examined associations between iron and selenium
status. We tested these hypotheses using dietary and biochemical
data from the New Dietary Strategies Addressing the Specific
Needs of the Elderly (NU-AGE) study, whose primary aim was
to test the effects of consuming an MD for 1 y on inflammatory
responses in elderly Europeans, with 15 prespecified secondary
outcomes, including the effects of the intervention on nutritional
status. In this 1-y randomized controlled trial (RCT), a total
of 1294 people aged 65–79 y from 5 European countries
(France, Italy, the Netherlands, Poland, and the United Kingdom)
were randomly allocated to an intervention (MD) or control
group (19, 20).
Methods
The NU-AGE trial was conducted in 5 European centers
(Bologna in Italy, Norwich in the United Kingdom, Wageningen
in the Netherlands, Warsaw in Poland, and Clermont Ferrand in
France). A detailed description of the European Commission–
funded NU-AGE project has been reported elsewhere (19, 20). In
summary, 1294 participants aged 65–79 y were recruited through
local advertisements, media publicity, and general practitioner
surgeries between April 2012 and January 2014 to a 1-y dietary
RCT. Study participants were free-living and responsible for their
own dietary choices. Ineligibility criteria included any clinically
diagnosed chronic disease; the use of corticosteroids or insulin
medications; the recent use of antibiotics or vaccinations; a recent
change in habitual medication; the presence of a food allergy or
intolerance, necessitating a special diet; the presence of frailty,
according to the Fried criteria (21); or malnutrition (defined as a
BMI <18.5 kg/m2 or a >10% weight loss in the previous
6 mo). Using a computer program, participants were randomly
allocated to the intervention or control group (1:1 allocation ratio)
after stratification by gender, age, frailty status (pre-frail or non-
frail), and BMI. Technicians performing laboratory analyses were
blinded to the group assignment, but researchers carrying out
dietary assessments were not, due to practical impossibilities,
including the fact that the participants themselves knew to which
group they were assigned.
Dietary intervention
Participants randomly assigned to the intervention group
received individually tailored dietary advice in order to meet the
study dietary requirements, as has been described previously
(20, 22). This individually tailored dietary advice, either given
face-to-face or by telephone by a trained dietitian/research
nutritionist, was administered 9 times during the year and
supported bymail or e-mail. To enhance compliance andmeet the
dietary guidelines, participants in the intervention group received
commercially available foods, including whole-grain pasta; extra
virgin olive oil; low-fat, low-salt cheese; high–polyunsaturated
fat margarine; and vitamin D supplements (10 μg/d).
Adherence was monitored at Months 4 and 8 with the use of 3-d
food diaries and the return of unused vitamin D supplements.
Participants randomly assigned to the control group were
requested to continue with their usual diet for the year and
provided with a generally available leaflet that outlined current
dietary guidance.
Dietary assessment
Dietary intake and compliance to the intervention were
evaluated by means of 7-d food records at the start and end of
the 1-y intervention. Participants received face-to-face training
in keeping complete and accurate food records, as well as
written instructions regarding the level of detail required to
describe foods and amounts consumed, including the name of
the food, preparation methods, recipes for mixed foods, and
portion sizes. At baseline and follow-up, food records were
reviewed during a 1-h interview with a trained dietitian/research
nutritionist. Nutrient intake was estimated by the use of local food
composition tables from France (23), Italy (24), the Netherlands
(25), Poland (26), and the United Kingdom (27). Data for
selenium intakes were not available for participants from Poland
and France.
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FIGURE 1 Flow chart of participants in the New Dietary Strategies Addressing the Specific Needs of the Elderly Population for Healthy Aging in Europe
(NU-AGE) trial. AGP, ɑ1 acid glycoprotein; CRP, C-reactive protein; sTfR, soluble transferrin receptor.
Blood sampling and storage
Blood samples were obtained after participants had fasted (at
least 8 h) and had avoided heavy exercise and alcohol in the
prior 24 h. Samples were centrifuged after sitting for 30 min at
room temperature, then were aliquoted and stored at−80◦C until
analysis.
Biochemical analysis
Serum iron, ferritin, sTfR, and α1 acid glycoprotein (AGP)
were measured using the COBAS system (Roche Diagnostics).
We measured sTfR and AGP by immunoturbidimetric assay,
performed on the c501 analyzer. The inter-assay CV for sTfRwas
<6.0% across the range between 0.5–40.0 mg/L and the inter-
assay CV for AGP was <2.7% across the range between 0.1–
4.0 g/L. Ferritin was measured by electro-chemiluminescence
immunoassay on the c601 analyzer. The inter-assay CV for
ferritin was <4.2% across the range between 0.5–2000 μg/L.
C-reactive protein (CRP) was measured by ProcartaPlexTM
Immunoassay (eBioscience), performed using Luminex 200
instrumentation (Luminex Corporation), according to the man-
ufacturer’s instructions.
Serum selenium was measured using a Platform XS Induc-
tively Coupled Plasma Mass Spectrometer (ICP-MS; Micro-
mass), with a plasma gas (argon) nebulizer flow rate of 1.0 L/min.
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TABLE 1 Baseline characteristics of the NU-AGE study participants, according to intervention group1
Intervention group Control group
n
Mean ± SD or
n (%) n
Mean ± SD or
n (%) P
Sex, female 568 321 ± 56.5 574 312 ± 54.4 0.463
Age, y 568 70.7 ± 4.0 574 71.0 ± 3.9 0.100
BMI, kg/m2 568 26.7 ± 4.1 574 26.6 ± 3.7 0.712
Serum ferritin, μg/L 557 139 ± 139 561 134 ± 104 0.433
Soluble transferrin receptor, mg/L 561 5.4 ± 1.6 566 5.4 ± 1.3 0.916
Body iron, mg/kg 557 9.4 ± 3.1 561 9.2 ± 3.1 0.339
Serum selenium, μmol/L 534 1.2 ± 0.3 542 1.1 ± 0.3 0.022
CRP, mg/L 563 1.7 ± 2.3 566 1.8 ± 2.4 0.539
AGP, g/L 561 0.7 ± 0.2 566 0.7 ± 0.2 0.464
Iron deficiency,2 yes 563 7 (1.2) 569 6 (1.1) 0.766
Inflammation,3 yes 567 58 (10.2) 573 66 (11.5) 0.485
Iron intake, mg/d 565 11.9 ± 3.6 572 12.5 ± 3.9 0.009
Selenium intake,4 μg/d 365 42.0 ± 15.3 365 43.1 ± 16.7 0.349
Meat intake, g/d 565 86.2 ± 48.5 572 88.0 ± 52.0 0.532
Fish intake, g/d 565 35.8 ± 29.7 572 36.0 ± 33.0 0.937
1n = 1142. P values were calculated using independent sample t-tests or chi-squared test for categorical data. AGP, ɑ1 acid glycoprotein; CRP,
C-reactive protein; NU-AGE, New Dietary Strategies Addressing the Specific Needs of the Elderly Population for Healthy Aging in Europe.
2Defined as serum ferritin <15 μg/L.
3Defined as a CRP concentration >5 mg/L and/or AGP concentration >1 g/L.
4Selenium intakes were not available for the Polish and French cohorts.
Helium (flow 10 mL/min) and hydrogen (flow 1.0 mL/min)
were used as hexapole/reaction cell gases, to facilitate the in-
cell reaction and minimize spectral interferences from argon-
based molecular ions (28). Elemental selenium was monitored
at a mass-to-charge ratio of 80. Prior to analysis, 50 μL of
serum samples, standards, and quality controls were diluted
with 2450 μL of a pre-treatment solution consisting of rhodium
internal standard (Fisher Scientific) in 2% nitric acid: water (v/v).
Rhodium was monitored at a mass-to-charge ratio of 103. The
pre-treated samples were infused into the ICP-MS at 1 mL/
min, using a Gilson Minipuls 3 peristaltic pump (Villiers le
Bel). Matrix-matched selenium calibrators were prepared by
spiking certified, National Institute of Standards and Technology
traceable, pure selenium standard (SPEX CertiPrep) into fetal
calf serum, to produce a 4-point calibration curve over the
analytical range of 0.1–3.17 μmol/L. Assay performance was
assessed with the use of internal quality controls (Trace Elements
Serum Controls NR and HR, UTAK Laboratories) included in
each batch of analysis. The inter- and intra-assay CVs were
≤2.0% and ≤9.4%, respectively.
Ethics approval
Local ethical approval was provided by the Independent
Ethics Committee of the Sant’Orsola-Malpighi Hospital Bologna
(Italy), the National Research Ethics Committee–East of England
(United Kingdom), the Wageningen University Medical Ethics
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FIGURE 2 Baseline biomarkers of selenium intake and status by study center in 1244 men and women aged 65–79 y. Values are means (error bars show
95% CIs), adjusted for age, sex, baseline BMI, and smoking status. Data were missing for 449 selenium intake and 65 serum selenium values. Bars sharing a
letter were not significantly different after adjustment for multiple testing (q > 0.05), and were only tested where there was an overall significant difference
between countries (P < 0.05, ANCOVA).
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TABLE 2 Standardized associations between intake of foods rich in selenium, selenium intakes, and selenium status at baseline1
n β (95% CI) P R2
Selenium intake, μg/d
Meat, g/d 794 0.13 (0.06–0.20) <0.01 1.6%
Red and processed meat, g/d 794 0.04 (−0.03 to 0.11) 0.32 0.2%
Poultry, g/d 794 0.17 (0.10–0.24) <0.01 2.2%
Fish, g/d 794 0.45 (0.39–0.52) <0.01 18.3%
Cereal, g/d 794 0.15 (0.08–0.22) <0.01 2.4%
Nuts and seeds, g/d 794 0.06 (−0.01 to 0.13) 0.08 0.2%
Dairy, g/d 794 0.07 (0.00–0.14) 0.05 1.1%
Serum selenium, μmol/L
Selenium intakes, μg/d 767 0.20 (0.13–0.27) <0.01 2.8%
Meat, g/d 1176 0.03 (−0.02 to 0.09) 0.27 1.4%
Red and processed meat, g/d 1176 − 0.01 (−0.06 to 0.05) 0.78 2.3%
Poultry, g/d 1176 0.07 (0.02–0.12) 0.01 0.1%
Fish, g/d 1176 0.16 (0.11–0.21) <0.01 2.6%
Cereal, g/d 1176 − 0.14 (−0.20 and −0.08) <0.01 5.7%
Nuts and seeds, g/d 1176 0.06 (0.01–0.11) 0.02 0.6%
Dairy, g/d 1176 0.11 (0.06–0.16) <0.01 1.2%
1Values are the standardized β coefficients (95% CIs) relating to the difference in selenium intake or status per 1 SD difference in the intake of foods rich
in selenium, after adjustment for study center, age, sex, baseline BMI, and smoking status, n = 1176. The R2 values represent the variance in selenium intakes
or status explained by each variable. P values were calculated using linear regression models. Selenium intakes were not available for the Polish and French
cohorts.
Committee (Netherlands), the Bioethics Committee of the
Polish National Food and Nutrition Institute (Poland), and the
South-East 6 Person Protection Committee (France). All study
procedures were in accordance with the ethical standards of
the Helsinki Declaration. All participants gave informed consent
before participating. The trial was registered at clinicaltrials.gov
(NCT01754012).
Statistical analysis
We used a linear regression approach to adjust ferritin
concentrations by CRP, AGP, and sTfR by AGP, following the
recommendations of the Biomarkers Reflecting Inflammation
and Nutritional Determinants of Anemia (BRINDA) project,
using the maximum value of the lowest CRP (0.2 mg/L) or AGP
(0.5 g/L) decile at baseline as the reference value (29). Body
iron was calculated using the adjusted values of ferritin and
sTfR.
In cross-sectional analyses of baseline data, we used regression
models to assess differences in biomarkers of iron status,
selenium status, and dietary intake, by study center. If an overall
significant difference between study centers was found, we tested
the individual associations between each center, adjusting for
multiple testing using the Benjamini and Hochberg method for
false discovery rate. We also examined the associations between
biomarkers of iron and selenium status and dietary intakes, and
between selenium and iron biomarkers. All models were adjusted
for sex, age, BMI, and smoking status.
Between-intervention group differences in participant char-
acteristics were assessed using independent sample t-tests. The
effect of the intervention on biomarkers of iron and selenium
status and dietary intake were assessed using linear mixed-
effect models, with participant included as a random effect, time,
treatment group, time x treatment group interaction, and the
explanatory variables study center, age, sex, baseline BMI, and
smoking status. For each variable, we tested for an interaction
with sex; where we found a significant interaction, we conducted
a stratified analysis. In a sensitivity analysis, we performed
multiple imputations of missing data using Markov-chain Monte
Carlo methods with 17 imputations (equal to the maximum
percentage of incomplete cases), in order to conduct an intention-
to-treat analysis. We examined the 1-y change in iron status by
each quintile of change in serum selenium using an ANCOVA
adjusted for intervention group, study center, age, sex, baseline
BMI, and smoking status. All analyses were performed using
STATA (version 15; StataCorp).
Results
Cross-sectional analysis of baseline data
Of the 1294 participants recruited to the NU-AGE study,
1142 completed the study (11.7% drop-out rate; Figure 1;
Table 1). Participants in the United Kingdom (44 mg/d) and
the Netherlands (45 mg/d) had significantly higher selenium
intakes, compared to those in Italy (38 mg/d), at baseline;
data were not available for participants in Poland or France
(Figure 2).Meat intakeswere significantly higher for participants
in Poland (111 g/d) and France (111 g/d), in comparison to
those at the other study centers (P < 0.01), but there were no
between-center differences in fish intakes (P = 0.79) at baseline
(Figure 2). A comparison of the standardized β coefficients
representing the relationship between selenium intake and foods
rich in selenium showed that meat, poultry, fish, and cereals
had the greatest associations with selenium intake; there was no
significant association between the intake of nuts and selenium
intake (Table 2). Fish intake explained 18.3% of the variation in
selenium intakes, with red meat, poultry, cereals, and dairy each
contributing ≤3% (Table 2).
There were significant differences in baseline serum selenium
concentrations between study centers (Figure 2). The highest
serum selenium concentrations were found in participants
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FIGURE 3 Associations between selenium intake and serum selenium status at baseline in 767 men and women aged 65–79 y, by study center. The scatter
plots represent the association of selenium intake with serum selenium status. The regression lines and P values were calculated from linear regression, and r
indicates a partial correlation coefficient. All models were adjusted for age, sex, baseline BMI, and smoking status.
in the United Kingdom (1.33 μmol/L, 95% CI: 1.31–1.36)
and the lowest concentrations were in participants in Poland
(0.97 μmol/L, 95% CI: 0.94–1.00) and France (0.97 μmol/L,
95% CI: 0.94–1.00). There was a significant association between
selenium intake and serum selenium (P < 0.01), although
selenium intake only explained 3% of the variation in serum
selenium concentrations (Table 2). There was a significant
intake × study center interaction (P < 0.01, data not shown)
for selenium intakes, with significant positive associations at
baseline in participants in the United Kingdom (P < 0.01) and
the Netherlands (P= 0.01), but not those in Italy (P= 0.18), after
adjustment for sex, age, smoking status, and BMI (Figure 3).
Intakes of poultry, fish, cereals, and dairy were significantly
associated with selenium status, although they explained a
relatively small amount of the variation (0.1%, 2.6%, 5.7%, and
1.2%, respectively; Table 2).
Baseline serum ferritin concentrations (P < 0.01) and
calculated body iron (P < 0.01) were highest in participants in
France and lowest in those in the United Kingdom (Figure 4).
No significant differences between countries were observed for
sTfR (P = 0.86). Estimated mean dietary intakes of iron were
highest in participants in France (13.7 mg/d) and lowest in those
in the Netherlands (10.8 mg/d; P < 0.01; Figure 4). There was
no association between total iron intake and body iron (Table 3).
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FIGURE 4 Baseline biomarkers of iron intake and status by study center in 1247 men and women aged 65–79 y. Values are means (error bars indicate
95% CIs), adjusted for age, sex, baseline BMI, and smoking status. Serum ferritin values were adjusted for CRP, AGP, and sTfR for AGP, using a regression
correction. Body iron was calculated using inflammation-adjusted values for ferritin and sTfR. Data were missing for 118 serum ferritin and body iron and
15 sTfR values. Bars sharing a letter were not significantly different after adjustment for multiple testing (q > 0.05), and were only tested where there was an
overall significant difference between countries (P < 0.05, ANCOVA). AGP, ɑ1 acid glycoprotein; CRP, C-reactive protein; sTfR, soluble transferrin receptor.
Higher meat intake was associated with higher concentrations of
serum ferritin (P< 0.01) and body iron (P< 0.01), but explained
only 1.5 to 2.5% of the variation.
At baseline, higher serum selenium concentrations were
associated with higher serum ferritin concentrations (r = 0.11;
P < 0.01) and higher body iron (r = 0.10; P < 0.01), but not
sTfR (r= −0.03; P= 0.38; Figure 5). There were no significant
interactions by study center (data not shown).
Effects of intervention
Selenium intakes and biomarkers of selenium or iron status
did not differ between the control and intervention groups at
baseline, but iron intakes were higher in the controls (12.5 mg/d),
compared to the intervention group (11.9 mg/d; Table 1).
Although calculated selenium intakes increased significantly in
the intervention (P< 0.01), there was no effect on selenium status
in a complete case analysis (P = 0.91; Table 4) or when missing
data were imputed (P = 0.83; Supplemental Table 1).
When data from all study sites were combined, there was
an increase in iron intake resulting from the intervention
(P < 0.001), but there were no changes in iron status in the
complete case or imputed analyses (Table 4; Supplementary
Table 1). There was a significant interaction with sex for sTfR
only (P = 0002). When stratified by sex, we found a significant
time × treatment interaction for women (P < 0.01), but not
men (P = 0.18), with an increase in sTfR in the intervention
group (data not shown). Meat intake decreased and fish intake
TABLE 3 Standardized associations between intake of foods rich in iron, iron intakes, and biomarkers of iron status at baseline1
n β (95% CI) P R2
Iron intake, mg/d
Meat, g/d 1244 0.20 (0.14–0.25) <0.01 5.0%
Red and processed meat, g/d 1244 0.18 (0.13–0.24) <0.01 4.5%
Poultry, g/d 1244 0.07 (0.01–0.12) 0.01 0.6%
Fish, g/d 1244 0.15 (0.10–0.20) <0.01 2.2%
Serum ferritin, μg/L
Meat, g/d 1127 0.12 (0.06–0.18) <0.01 2.5%
Red and processed meat, g/d 1127 0.13 (0.07–0.19) <0.01 2.6%
Poultry, g/d 1127 0.03 (−0.03 to 0.09) 0.31 0.2%
Fish, g/d 1127 0.04 (−0.01 to 0.10) 0.14 0.2%
Iron, mg/d 1129 − 0.01 (−0.07 to 0.05) 0.83 0.1%
Body iron, mg/kg
Meat, g/d 1127 0.09 (0.03–0.15) <0.01 1.5%
Red and processed meat, g/d 1127 0.09 (0.03–0.16) <0.01 1.5%
Poultry, g/d 1127 0.03 (−0.03 to 0.08) 0.37 0.1%
Fish, g/d 1127 0.06 (0.00–0.12) 0.04 0.4%
Iron, mg/d 1129 − 0.06 (−0.12 to 0.01) 0.08 0.1%
1Values are the standardized β coefficients (95% CIs) relating to the change in iron intake or status per 1 SD difference in the intake of foods rich in iron,
after adjustment for study center, age, sex, baseline BMI, and smoking status, n = 1244. The R2 values represent the variance in iron intakes or status
explained by each variable. P values were calculated using linear regression models. Serum ferritin values were adjusted for CRP and AGP and body iron was
calculated using the inflammation-adjusted values for ferritin and soluble transferrin receptor. AGP, ɑ1 acid glycoprotein; CRP, C-reactive protein.
D
ow
nloaded from
 https://academ
ic.oup.com
/ajcn/article-abstract/111/1/98/5574658 by guest on 17 M
arch 2020
Mediterranean-style diet and iron and selenium 105
n = 1173; r = -0.03; P = 0.38
0
5
10
15
20
25
0 1 2 3 4
L/g
m,rotpecer
nirrefsnart
elbuloS
Serum selenium, μmol/L
n = 1079; r = 0.11; P < 0.01
0
200
400
600
800
1000
1200
0 1 2 3 4
Se
ru
m
 fe
rr
i
n,
 μ
g/
L 
Serum selenium, μmol/L
n = 1079; r = 0.10; P < 0.01
-5
0
5
10
15
20
0 1 2 3 4
Bo
dy
 ir
on
, m
g/
kg
Serum selenium, μmol/L
FIGURE 5 Associations between serum selenium and biomarkers of iron status at baseline in 1173 men and women aged 65–79 y. The scatter plots
represent the association of selenium status with biomarkers of iron status. The regression lines and P values were calculated from linear regression, and r
indicates a partial correlation coefficient. Serum ferritin values were adjusted for CRP, AGP, and sTfR for AGP using a regression correction. Body iron was
calculated using the inflammation-adjusted values for ferritin and sTfR. All models were adjusted for study center, age, sex, baseline BMI, and smoking status.
Data were missing for 94 serum ferritin and body iron values. AGP, ɑ1 acid glycoprotein; CRP, C-reactive protein; sTfR, soluble transferrin receptor.
increased to a greater degree in the intervention group, relative
to the controls (P < 0.01 for both; Table 4). We examined
the main food sources of iron intake in the intervention group
at baseline and at the 1-y follow-up (data available for UK
cohort only; Supplemental Table 2). The greatest differences
were for refined and whole-grain cereals; at baseline, 14.1% of
the iron intake came from refined cereals, compared to only
5.3% of the iron at follow-up. Conversely, at baseline 19.3%
of iron intake came from whole-grain cereals, compared to
30.9% at follow-up. Other notable differences were for sugar
and confectionary, which contributed 7.4% to the total intake at
baseline, compared to 5.3% at follow-up. There were no clear
changes observed in the foods that contributed to iron intake
in the control group over the 1-y intervention (Supplemental
Table 2).
The change in selenium status over the 1-y intervention was
associated with greater changes in serum ferritin (P < 0.01) and
body iron (P = 0.01), but not sTfR (P = 0.68; Figure 6). There
were no study center × selenium status interactions for the iron
biomarkers (P > 0.05 for all; data not shown).
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TABLE 4 Iron and selenium status and dietary intakes after 1 y of follow-up in the intervention and control diet groups1
Control group Intervention group
Variable n Baseline 1-y follow-up n Baseline 1-y follow-up P
Serum selenium, μmol/L 542 1.11 (1.09–1.12) 1.11 (1.09–1.13) 534 1.13 (1.11–1.15) 1.13 (1.11–1.15) 0.91
Selenium intake, μg/d 365 42.0 (40.4–43.7) 41.0 (39.4–42.7) 365 40.4 (38.8–42.0) 51.6 (49.8–53.4) <0.01
Serum ferritin, μg/L 561 106 (100–112) 108 (102–114) 557 113 (107–119) 114 (107–120) 0.41
Soluble transferrin receptor, mg/L 566 5.23 (5.12–5.35) 5.25 (5.13–5.36) 561 5.19 (5.07–5.30) 5.33 (5.21–5.44) 0.06
Body iron, mg/kg 561 8.67 (8.40–8.95) 8.74 (8.47–9.02) 557 8.96 (8.68–9.24) 8.99 (8.70–9.27) 0.62
Iron intake, mg/d 572 12.0 (11.8–12.3) 11.9 (11.6–12.1) 565 11.6 (11.4–11.9) 12.7 (12.4–13.0) <0.01
Meat, g/d 572 80.4 (77.1–83.7) 79.0 (75.7–82.3) 565 80.6 (77.2–83.9) 67.0 (63.9–70.1) <0.01
Red and processed meat, g/d 572 59.0 (56.1–61.8) 59.9 (57.0–62.8) 565 59.6 (56.6–62.5) 47.2 (44.5–49.8) <0.01
Poultry, g/d 572 16.7 (15.1–18.3) 14.5 (13.0–16.0) 565 16.5 (14.9–18.1) 15.3 (13.8–16.9) 0.28
Fish, g/d 572 33.2 (31.0–35.4) 27.2 (25.1–29.3) 565 31.8 (29.6–34.0) 38.6 (36.1–41.0) <0.01
1Values are means (95% CIs), adjusted for study center, age, sex, baseline BMI, and smoking status, n = 1137. P values are for the time × treatment
interaction, calculated from linear mixed effect models. Serum ferritin values were adjusted for CRP, AGP, and sTfR for AGP using a regression correction.
Body iron was calculated using the inflammation-adjusted values for ferritin and sTfR. Selenium intakes were not available for the Polish and French cohorts.
AGP, ɑ1 acid glycoprotein; CRP, C-reactive protein; sTfR, soluble transferrin receptor.
Discussion
The main finding of this study was that consuming an MD
for 1 y had no effect on iron and selenium statuses, despite
significant changes in iron and selenium intakes. The decrease
in meat intake (from 80.6 to 67.0 g/d) when changing from a
habitual diet to an MD, did not result in a lower iron status,
and an increase in fish intake (from 31.8 to 38.6 g/d) was
not accompanied by a higher serum selenium concentration.
However, there were differences between the study sites; serum
ferritin increased significantly in participants in Italy, the
Netherlands, and France, but not in those in the United Kingdom
or Poland. This could be related to the differences in iron or
meat intake (Supplemental Table 1). In all sites except Poland,
participants’ iron intakes were significantly higher as a result of
the intervention (P < 0.01), and there were also differences in
mean baseline serum ferritin values (P < 0.05), whichmight have
affected the sensitivity of responses to a change in iron intake.
Themeat intakewas lower than that reported for people aged 65 y
and over in the UK National Diet and Nutrition Survey (30).
Serum ferritin is a quantitativemeasure of the amount of iron in
body stores (13). However, with infection or inflammation, serum
ferritin is raised (13), so we adjusted serum ferritin values for
infection/inflammation, using the approach recommended from
the BRINDA project (29), to obtain values that reflected iron
stores. Body iron, the ratio of serum transferrin receptor to serum
ferritin (31), has been shown to be themost sensitive indicator of a
change in iron status following iron supplementation and is more
reliable than either parameter alone for the identification of iron
deficiency (13). The prevalence of iron deficiency in our study
population was extremely low, with only 1.1% of participants
having SF concentrations below 15 μg/L at baseline.
The overall mean intake of selenium, calculated using country-
specific food composition tables, was approximately 42 μg/d at
baseline, but increased to 52 μg/d with the intervention. When
standardized associations between the intake of selenium-rich
foods and selenium intakes at baseline were examined, fish
intake accounted for 18% of the variance in selenium intakes.
The importance of fish in relation to selenium status is well
established. Bates et al. (16) reported that in the UK National
Diet and Nutrition Survey, dietary fish was a strong predictor
of plasma and red cell selenium concentrations, and Filippini et
al. (32) observed a positive association between the intake of
fish, legumes, and dry fruits with plasma selenium. In an RCT,
Scheers et al. (17) found a significant increase in plasma selenium
in overweight Swedish men after they consumed herring for
6 weeks.
The Italian center had the lowest estimated mean selenium
intake (37 μg/d), which increased to 57 μg/d as a result of
the intervention. The US National Academies of Sciences,
Engineering, and Medicine Estimated Average Requirement
(EAR) for selenium in men and women aged 51 y and older is
45 μg/d (33). The US EAR was achieved in participants from
the United Kingdom and the Netherlands, but the average intake
of the Italian participants was slightly lower, although when
consuming the MD their intake exceeded the EAR.
Average plasma selenium concentrations in European adults
range from 0.61–1.57 μmol/L (34), and concentrations from
0.9–1.3 μmol/L have been proposed by different authors to
reflect selenium adequacy (35). In our study, the overall mean
serum selenium concentration was 1.12 μmol/L at baseline, and
remained unchanged after the intervention, despite an apparent
increase in selenium intake. Although the 7-d food record is
a reliable proxy of short-term current dietary intakes in the
elderly (36), this may be a reflection of the inaccurate nature
of food composition tables, as the selenium content of food is
greatly affected by environmental factors, such as soil selenium
(37).
It has been reported that low serum selenium is an independent
risk factor for anemia in older women living independently in
the United States (18). This finding was obtained from cross-
sectional analyses and agrees with data from the UK National
Diet and Nutrition Survey, in which a positive correlation
between plasma selenium and hemoglobin was reported in people
aged 65 y and over (38). A potential mechanism by which
selenium could contribute to anemia is through the maintenance
of optimal glutathione peroxidase concentrations in erythrocytes,
a key antioxidant selenoenzyme (39). We found that an increase
in serum selenium was accompanied by higher serum ferritin and
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FIGURE 6 The 1-y change in biomarkers of iron status, by quintile of change in serum selenium, in 1077 men and women aged 65–79 y. Values are means
(error bars indicate 95% CIs), adjusted for study center, age, sex, baseline BMI, smoking status, and group status. Serum ferritin values were adjusted for CRP,
AGP, and sTfR for AGP, using a regression correction. Body iron was calculated using the inflammation-adjusted values for ferritin and sTfR. P values are for
trends calculated using an ANCOVA. AGP, ɑ1 acid glycoprotein; CRP, C-reactive protein; Q, quintile; sTfR, soluble transferrin receptor.
body iron (P= 0.01), but there was no effect on hemoglobin. The
observed effect of changes in serum selenium on iron status is
intriguing and could represent an early stage of the interaction
that eventually leads to anemia.
The daily intake of iron was nearly twice the average
requirement of 6 mg/d (40). We observed a significant increase
in iron intake for those in the MD group, which agrees with other
published findings (5). It appears that despite a reduction in meat
intake, the MD provides sufficient bioavailable iron to maintain
body iron; depending on the baseline habitual diet, changing to
an MD may actually induce a subtle increase in iron status.
The main strengths of this RCT were the study size (1294
elderly men and women from 5 different regions of Europe)
and the length of the intervention (1 y). The exclusion criteria
were kept to a bare minimum, as we wanted to recruit a
representative group of elderly people. However, there was a
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degree of self-selection, as the more nutritionally aware members
of the community were more interested in volunteering for
dietary studies. The success of the intervention was facilitated
through a personalized approach, in which every volunteer was
interviewed and dietary changes were tailored to their food
preferences. Compliance analyses, assessed through 7-d food
records collected at the start and end of the 1-y intervention,
showed improved adherence to an MD following the NU-AGE
approach (22). Seasonal variations in dietary patterns and food
intake (with potential impacts on nutritional status) were avoided
by running the intervention for a full year; with staggered starting
dates for the volunteers, any confounding effects of season were
minimized. As the primary aim of the trial was to examine the
effect of the MD on inflammaging, the measures of nutritional
status were secondary outcomes and, therefore, were more
limited in scope. It was, for example, not possible to measure
whole-blood iron status biomarkers or tomeasure selenoprotein P
as a biomarker of selenium status. The fact that themajority of our
volunteers were apparently healthy at baseline may explain why
the MD did not change iron and selenium statuses, but it would
be interesting to undertake a similar intervention with individuals
selected for low iron and selenium status.
The results of our RCT demonstrated that an MD significantly
increased iron and selenium intakes, but had no overall effect on
iron or selenium statuses, although a small increase in iron status
was observed in participants in 3 of the 5 countries participating
in the trial. These findings add weight to the body of evidence
underpinning recommendations to consume an MD to improve
overall health.
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